OF THE
TIMES
In June, the EPA found "no convincing evidence" glyphosate acts as an endocrine disruptor. How the agency reached this conclusion involved quite a bit of distortion and manipulation, as The Intercept points out in a recent report:But the EPA's exoneration — which means that the agency will not require any further tests of the chemicals' effects on the hormonal system — is undercut by the fact that the decision was based almost entirely on pesticide industry studies. Only five independent studies were considered in the review of whether glyphosate interferes with the endocrine system. Twenty-seven out of 32 studies that looked at glyphosate's effect on hormones and were cited in the June review — much of which are not publicly available and were obtained by The Intercept through a Freedom of Information Act request — were either conducted or funded by the industry. Most of the studies were sponsored by Monsanto or an industry group called the Joint Glyphosate Task Force. One study was by Syngenta, which sells its own glyphosate-containing pesticide, Touchdown.
President-elect Trump has some doubts about the current vaccine policies, and he has questions about it. His opinion doesn't matter, but the science does matter, and we ought to be reading the science, and we ought to be debating the science. - Robert F. Kennedy Jr.The response has triggered inflammatory editorials from government-sanctioned mainstream news sources to send an orchestrated message that not only is "Fundamentalist Trumpism" dangerous for questioning vaccines, but his supporters are "anti-vaccine fanatics."
"In its simplest definition it (right care) is care that weighs up benefits and harms, is patient-centred (taking individual circumstances, values, and wishes into account), and is informed by evidence, including cost-effectiveness."In the paper that focuses on evidence for overuse of medical services, the authors Brownlee and her colleagues make a distinction between services that are clearly and universally beneficial when used on the right patient and services that are definitely inappropriate. However, they point out, most services lie within a "grey zone" where the risk-benefit profile varies widely depending on the patient (e.g. antidepressants for adolescents). Moreover, decision making in providing these services is often based on physician assumptions and biases rather than being grounded in client preferences. They report on overuse measured in two ways - directly through registries and medical records and indirectly, through geographical variation in service utilization that is not linked to the populations serviced.
Comment: